Named as a key player in 33 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Over The Counter (OTC) Sleep Aid Products | OTC & Nutraceuticals | $5.3 Bn | 4% |
Named as key players in the same markets as Koninklijke Philips NV. (number of shared markets).
AstraZeneca1 shared market
Biodem1 shared market
Cadwell Industries, Inc1 shared market
Fisher & Paykel Healthcare Limited1 shared market
GSK PLC1 shared market
Merck & Co., Inc.1 shared market
Novartis AG1 shared market
Pfizer Inc.1 shared market
Search all reports for Koninklijke Philips NV. All companies